Neogenomics (NEO) Liabilities from Discontinued Operations (2025)

Neogenomics (NEO) reported Liabilities from Discontinued Operations of 478000.0 for Q3 2025, up 4.82% quarter-over-quarter from 456000.0 in Q2 2025.

Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends

Neogenomics has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 478000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Neogenomics	1.48 Bn	1.33 Bn	80.86 Mn

Download Data